SEC Form 4 · accession 0001209191-18-042871
Minerva Neurosciences, Inc. · NERV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jeryl L Hilleman
Director
Period of report
Jul 16, 2018
Accepted (ET)
Jul 17, 2018 · 4:45 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001598646
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $8.20 | Jul 16, 2018 | A | 40,000 | A | — | Jul 16, 2028 | Common Stock | 40,000 | 40,000 | D |
Explanation of responses
- F1The shares subject to this option vest in equal monthly installments commencing on the one-month anniversary of July 16, 2018, subject to the continued service of the Reporting Person as a non-employee director on each vesting date.